It can attenuate the signs of Huntington’s disease and reduce levels of a mutant huntingtin fragment in a mice mouse model [86] and early clinical evidence appears promising for repurposing rilmenidine for Huntington’s disease [87]. Here, HTT is linked to Huntington disease.